School-based screening and treatment may reduce P. falciparum transmission.
Antimalarials
/ therapeutic use
Artemether, Lumefantrine Drug Combination
/ therapeutic use
Child
Cohort Studies
Female
Humans
Malaria, Falciparum
/ diagnosis
Malawi
Male
Mass Screening
/ statistics & numerical data
Plasmodium falciparum
/ isolation & purification
School Health Services
/ statistics & numerical data
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 03 2021
25 03 2021
Historique:
received:
18
01
2021
accepted:
16
03
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
28
10
2021
Statut:
epublish
Résumé
In areas where malaria remains entrenched, novel transmission-reducing interventions are essential for malaria elimination. We report the impact screening-and-treatment of asymptomatic Malawian schoolchildren (n = 364 in the rainy season and 341 in the dry season) had on gametocyte-the parasite stage responsible for human-to-mosquito transmission-carriage. We used concomitant household-based surveys to predict the potential reduction in transmission in the surrounding community. Among 253 students with P. falciparum infections at screening, 179 (71%) had infections containing gametocytes detected by Pfs25 qRT-PCR. 84% of gametocyte-containing infections were detected by malaria rapid diagnostic test. While the gametocyte prevalence remained constant in untreated children, treatment with artemether-lumefantrine reduced the gametocyte prevalence (p < 0.0001) from 51.8 to 9.7% and geometric mean gametocyte density (p = 0.008) from 0.52 to 0.05 gametocytes/microliter. In community surveys, 46% of all gametocyte-containing infections were in school-age children, who comprised only 35% of the population. Based on these estimates six weeks after the intervention, the gametocyte burden in the community could be reduced by 25-55% depending on the season and the measure used to characterize gametocyte carriage. Thus, school-based interventions to treat asymptomatic infections may be a high-yield approach to not only improve the health of schoolchildren, but also decrease malaria transmission.
Identifiants
pubmed: 33767384
doi: 10.1038/s41598-021-86450-5
pii: 10.1038/s41598-021-86450-5
pmc: PMC7994823
doi:
Substances chimiques
Antimalarials
0
Artemether, Lumefantrine Drug Combination
0
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6905Subventions
Organisme : NIAID NIH HHS
ID : K24 AI114996
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI089683
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI135076
Pays : United States
Références
Malar J. 2016 Feb 29;15:127
pubmed: 26928321
BMC Public Health. 2009 Oct 01;9:369
pubmed: 19796380
Lancet Glob Health. 2020 Dec;8(12):e1499-e1511
pubmed: 33222799
PLoS Med. 2016 Nov 22;13(11):e1002175
pubmed: 27875528
PLoS One. 2014 Oct 07;9(10):e107700
pubmed: 25290939
BMJ Glob Health. 2017 Jun 28;2(2):e000182
pubmed: 29081992
Br Med J. 1951 May 19;1(4715):1114-7
pubmed: 14830852
Ann Trop Med Parasitol. 1985 Dec;79(6):549-62
pubmed: 3914860
Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):629-33
pubmed: 8594677
PLoS Med. 2017 Nov 30;14(11):e1002456
pubmed: 29190300
PLoS One. 2016 Jun 09;11(6):e0156717
pubmed: 27281028
PLoS Med. 2017 Nov 30;14(11):e1002452
pubmed: 29190279
J Infect Dis. 2016 Jan 1;213(1):90-9
pubmed: 26142435
Malar J. 2016 Nov 4;15(1):527
pubmed: 27809907
Malar J. 2017 Nov 09;16(1):456
pubmed: 29121931
Malar J. 2015 Dec 30;14:528
pubmed: 26714465
Lancet Glob Health. 2018 Jun;6(6):e668-e679
pubmed: 29661635
Malar J. 2018 Apr 3;17(1):147
pubmed: 29615044
J Infect Dis. 2006 Aug 1;194(3):276-85
pubmed: 16826474
Nat Commun. 2017 Oct 26;8(1):1133
pubmed: 29074880
PLoS One. 2015 Jul 24;10(7):e0134061
pubmed: 26207758
Elife. 2018 May 31;7:
pubmed: 29848446
Nat Rev Microbiol. 2014 Dec;12(12):833-40
pubmed: 25329408
Trends Parasitol. 2015 Jul;31(7):287-96
pubmed: 25985898
Trop Med Int Health. 2014 Nov;19(11):1294-309
pubmed: 25145389
Malar J. 2008 Jul 08;7:123
pubmed: 18611271
Malar J. 2016 Aug 19;15(1):421
pubmed: 27543112